Evidence map›Paper›PMID 26134644›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Prefrontal and Striatal Glutamate Differently Relate to Striatal Dopamine: Potential Regulatory Mechanisms of Striatal Presynaptic Dopamine Function?

Tobias Gleich, Lorenz Deserno, Robert Christian Lorenz, Rebecca Boehme, Anne Pankow, Ralph Buchert, Simone Kühn, Andreas Heinz, Florian Schlagenhauf, Jürgen Gallinat

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Chronic cannabis use alters dACC-striatal glutamatergic balance.Pharmacology, biochemistry, and behavior · 2023
    Article
  11. Glutamatergic dysfunction in Schizophrenia.Translational psychiatry · 2022
    Review
  12. Lower dACC glutamate in cannabis users during early phase abstinence.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Tobias GleichDepartment of Psychiatry and Psychotherapy and NeuroCure Cluster of Excellence in Medical Neuroscience, Charité-University Medicine Berlin, 10117 Berlin, Germany, tobias.gleich@charite.de.ORCID http://orcid.org/0000-0003-1106-0319
Lorenz DesernoDepartment of Psychiatry and Psychotherapy and Neurology and Max Planck Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany.ORCID http://orcid.org/0000-0001-7392-5280
Robert Christian LorenzDepartment of Psychiatry and Psychotherapy and Institute of Psychology, Humboldt University, 12489 Berlin, Germany.ORCID http://orcid.org/0000-0003-3286-6792
Rebecca BoehmeDepartment of Psychiatry and Psychotherapy and.
Anne PankowDepartment of Psychiatry and Psychotherapy and.
Ralph BuchertDepartment of Nuclear Medicine, Charité-University Medicine Berlin, 12200 Berlin, Germany.
Simone KühnDepartment of Psychiatry and Psychotherapy and Center for Lifespan Psychology, Max Planck Institute for Human Development, 14195 Berlin, Germany, and.
Andreas HeinzDepartment of Psychiatry and Psychotherapy and.
Florian SchlagenhaufDepartment of Psychiatry and Psychotherapy and Max Planck Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany.
Jürgen GallinatDepartment of Psychiatry and Psychotherapy and Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany.
Charité - Universitätsmedizin Berlin · DEHumboldt-Universität zu Berlin · DEMax Planck Institute for Human Cognitive and Brain Sciences · DEMax Planck Institute for Human Development · DENeurology, Inc · USUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Theoretical and animal work has proposed that prefrontal cortex (PFC) glutamate inhibits dopaminergic inputs to the ventral striatum (VS) indirectly, whereas direct VS glutamatergic afferents have been suggested to enhance dopaminergic inputs to the VS. In the present study, we aimed to investigate relationships of glutamate and dopamine measures in prefrontostriatal circuitries of healthy humans. We hypothesized that PFC and VS glutamate, as well as their balance, are differently associated with VS dopamine. Glutamate concentrations in the left lateral PFC and left striatum were assessed using 3-Tesla proton magnetic resonance spectroscopy. Striatal presynaptic dopamine synthesis capacity was measured by fluorine-18-l-dihydroxyphenylalanine (F-18-FDOPA) positron emission tomography. First, a negative relationship was observed between glutamate concentrations in lateral PFC and VS dopamine synthesis capacity (n = 28). Second, a positive relationship was revealed between striatal glutamate and VS dopamine synthesis capacity (n = 26). Additionally, the intraindividual difference between PFC and striatal glutamate concentrations correlated negatively with VS dopamine synthesis capacity (n = 24). The present results indicate an involvement of a balance in PFC and striatal glutamate in the regulation of VS dopamine synthesis capacity. This notion points toward a potential mechanism how VS presynaptic dopamine levels are kept in a fine-tuned range. A disruption of this mechanism may account for alterations in striatal dopamine turnover as observed in mental diseases (e.g., in schizophrenia). SIGNIFICANCE STATEMENT: The present work demonstrates complementary relationships between prefrontal and striatal glutamate and ventral striatal presynaptic dopamine using human imaging measures: a negative correlation between prefrontal glutamate and presynaptic dopamine and a positive relationship between striatal glutamate and presynaptic dopamine are revealed. The results may reflect a regulatory role of prefrontal and striatal glutamate for ventral striatal presynaptic dopamine levels. Such glutamate-dopamine relationships improve our understanding of neurochemical interactions in prefrontostriatal circuits and have implications for the neurobiology of mental disease.

Indexed as

AdultCorpus StriatumDopamineFemaleFluorodeoxyglucose F18Glutamic AcidHumansImage Processing, Computer-AssistedMagnetic Resonance SpectroscopyMaleNeural PathwaysPositron-Emission TomographyPrefrontal CortexPresynaptic TerminalsStatistics as TopicYoung AdultDopamineFluorodeoxyglucose F18Glutamic AciddopamineFDOPA PETglutamateMRSprefrontal cortexstriatum

Identifiers

PMID26134644
PMCPMC6605144
OpenAlexW1621815751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.